In 2016, the multidrug-resistant fungal strain of Candida auris reappeared in the U.S., being traced back to a case in 2013. As of January 2025, nearly 3,000 cases have been reported in New York. A particular surge of cases during the COVID-19 pandemic led to many improvements in case screening and management by the New York Department of Health.
In this case study, Ramon discussed how the emergence of C. auris highlighted a need for improved surveillance, outbreak response measures, and increased public awareness of infection prevention and control strategies. Ramon notes that improved coordination, reporting practices, and effective communication could help public health agencies respond to emerging infectious threats.